<?xml version="1.0" encoding="UTF-8"?>
<p>Early symptoms and clinical features among pregnant patients are similar to nonpregnant patients, however, there is a high risk of rapid progression to poor maternal, obstetric and foetal outcome. These include deranged coagulogram, encephalopathy, death, intra-uterine death and premature deliveries [
 <xref rid="pone.0228068.ref015" ref-type="bibr">15</xref>â€“
 <xref rid="pone.0228068.ref019" ref-type="bibr">19</xref>]. Understanding mechanism(s) of disease severity and mortality in pregnant women is of utmost importance and relevance for the endemic countries. However, pathogenesis of hepatitis E in general and during pregnancy in particular is not well understood. This is primarily because of the lack of small laboratory animal model and inability of nonhuman primate models to replicate fulminant disease during pregnancy [
 <xref rid="pone.0228068.ref020" ref-type="bibr">20</xref>,
 <xref rid="pone.0228068.ref021" ref-type="bibr">21</xref>]. Recent reports of pregnant rabbit and BALB/c models may prove useful in understanding the basis for observed complications of HEV infection [
 <xref rid="pone.0228068.ref022" ref-type="bibr">22</xref>,
 <xref rid="pone.0228068.ref023" ref-type="bibr">23</xref>].
</p>
